Literature DB >> 28131182

Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease.

Roberta Balestrino1, Pablo Martinez-Martin2.   

Abstract

Parkinson's disease is a complex neurodegenerative disorder characterized by motor and non-motor symptoms, with neuropsychiatric manifestations among the most frequent non-motor symptoms. Health-related quality of life is a patient-reported outcome that reflects the impact of the disease on physical, mental, and social wellbeing, and on other aspects of patient' life. Although older studies on health-related quality of life in Parkinson's disease mainly investigated the role of the motor impairment, recent research focused on non-motor symptoms has highlighted the critical role that behavioural disturbances due to neuropsychiatric symptoms play in determining health related quality of life. A considerable number of studies have demonstrated the importance of depression as a determinant of health-related quality of life in this population, but less evidence is available regarding the role of other neuropsychiatric symptoms such as anxiety, apathy, psychosis, and impulse control disorders. This narrative review analyses recent literature on this topic, focusing on studies in which neuropsychiatric symptoms were investigated as potential determinants of quality of life using regression techniques, including discussion of the assessment tools used.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Assessment; Behavioural disorders; Neuropsychiatric disorders; Parkinson's disease; Quality of life

Mesh:

Year:  2016        PMID: 28131182     DOI: 10.1016/j.jns.2016.12.060

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  29 in total

1.  Single-Cell Approaches for Studying the Role of Mitochondrial DNA in Neurodegenerative Disease.

Authors:  Laura J Bailey; Joanna L Elson; Ilse S Pienaar
Journal:  Methods Mol Biol       Date:  2021

2.  Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.

Authors:  YongXin Hao; Aref Shabanpoor; Gerlinde A Metz
Journal:  Neurosci Lett       Date:  2017-05-01       Impact factor: 3.046

3.  Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson's Disease.

Authors:  Erinaldo Ubirajara Damasceno Dos Santos; Elaine Bandeira Cavalcanti Duarte; Laura Maria Ramos Miranda; Andore Guescel C Asano; Nadja Maria Jorge Asano; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Neuromolecular Med       Date:  2019-05-22       Impact factor: 3.843

Review 4.  Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.

Authors:  Luigi Trojano; Costanza Papagno
Journal:  Neurol Sci       Date:  2017-10-16       Impact factor: 3.307

Review 5.  The use of nonhuman primate models to understand processes in Parkinson's disease.

Authors:  Javier Blesa; Inés Trigo-Damas; Natalia López-González Del Rey; José A Obeso
Journal:  J Neural Transm (Vienna)       Date:  2017-03-29       Impact factor: 3.575

Review 6.  The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.

Authors:  Sandra Abou Kassm; Wadih Naja; Ramzi Haddad; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2021-03-03       Impact factor: 5.285

7.  Increased rapid eye movement density in Chinese patients with Parkinson's disease and RBD.

Authors:  Jun Zhu; Liyu Lu; Min Zhong; Xu Jiang; Zhuang Wu; Jingde Dong; Yang Pan; Li Zhang
Journal:  Neurol Sci       Date:  2020-07-16       Impact factor: 3.307

8.  Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.

Authors:  Erinaldo Ubirajara Damasceno Dos Santos; Isaura Isabelle Fonseca Gomes da Silva; Amdore Guescel C Asano; Nadja Maria Jorge Asano; Maria De Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Mol Biol Rep       Date:  2020-11-05       Impact factor: 2.316

9.  Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.

Authors:  Michelle S Antunes; Fernando Vagner Lobo Ladd; Aliny Antunes Barbosa Lobo Ladd; Amanda Lopez Moreira; Silvana Peterini Boeira; Leandro Cattelan Souza
Journal:  Metab Brain Dis       Date:  2020-10-15       Impact factor: 3.584

10.  Enhancing Quality of Life in Indian Parkinson's Disease Patients with Improved Measurement of Psychological Domains: A Perspective.

Authors:  Ashima Nehra; Priya Sharma; Avneesh Narain; Shivani Sharma; Garima Joshi; Priyanka Bhat; Rajesh Kumar Singh; Roopa Rajan; Vinay Goyal; Achal Kumar Srivastava
Journal:  Ann Indian Acad Neurol       Date:  2021-04-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.